Adcock Ingram will delist from the Johannesburg Stock Exchange JSE on 11 November 2025, with India's Natco Pharma acquiring all the minority shares of the 135-year-old company.
The company's story dates back to 1890, when it started as a small pharmacy in Krugersdorp, Gauteng.
The company grew to become one of South Africa's leading pharmaceutical companies, with a range of prescription, over-the-counter OTC, consumer and hospital products, valued at R12 billion.
Its brands include Myprodol, Panado, Allergex, Epi-Max, Corenza, Gen-Payne and more.
The company was first listed on the Johannesburg Stock Exchange in 1950, ten years after opening its first Pharmaceutical manufacturing facility.
After 50 years of trading, the group's majority shareholder, Tiger Brands, acquired all the minority shares of the company in 2000.
The company then became a wholly-owned subsidiary of Tiger Brands and was delisted from the JSE.
